Skip to main navigation
  • DEFLATEHAE.COM
  • Investors & News
  • Careers
  • Contact
Pharvaris N.V. homepage
  • Disease Focus
  • Community Commitment
  • Scientific Approach
    • Our Science
    • Pipeline
  • Scientific Publications
  • About Pharvaris
Pharvaris N.V. homepage
  • Disease Focus
  • Community Commitment
  • Scientific Approach
    • Our Science
    • Pipeline
  • Scientific Publications
  • About Pharvaris
  • DEFLATEHAE.COM
  • Investors & News
  • Careers
  • Contact

SEC Filing Details

Investor Menu

IR Nav

  • Overview
  • News & Events
    News Releases Events Publications
  • Financials
    SEC Filings Quarterly Results
  • Stock
    Stock Performance Analyst Coverage
  • Corporate Governance
    Governance Documents Leadership Board of Directors Committee Composition
  • Resources
    Investor FAQs Contact Us Email Alerts

Document Details

Form
6-K
Filing Date
Aug 14, 2024
Document Date
Jun 30, 2024
Form Description
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Group
Current Reports
Company
Pharvaris N.V.
Issuer
PHARVARIS N.V.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
XML - XBRL INSTANCE DOCUMENT
Pharvaris N.V.

©2026 Pharvaris N.V. © All Rights Reserved

Menu
  • Privacy Policy
  • Clinical Trial Privacy Notice
  • Global Privacy Laws
  • Terms of Use
CONTACT US
FOLLOW US